TPCW
TAK icon

TD Private Client Wealth’s Takeda Pharmaceutical TAK Stock Holding History

TD Private Client Wealth’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
22,050
-1,875
-8% -$31K 0.01% 569
2026
Q1 		$443K Buy
23,925
+14,101
+144% +$247K 0.01% 505
2025
Q4 		$153K Buy
9,824
+9,571
+3,783% +$137K ﹤0.01% 704
2025
Q3 		$3.7K Hold
253
– – ﹤0.01% 1177
2025
Q2 		$3.91K Sell
253
-64
-20% -$946 ﹤0.01% 1140
2025
Q1 		$4.71K Buy
317
+79
+33% +$1.11K ﹤0.01% 1086
2024
Q4 		$3.15K Hold
238
– – ﹤0.01% 1140
2024
Q3 		$3.38K Hold
238
– – ﹤0.01% 1133
2024
Q2 		$3.08K Buy
238
+123
+107% +$1.63K ﹤0.01% 1116
2024
Q1 		$1.6K Hold
115
– – ﹤0.01% 1145
2023
Q4 		$1.64K Hold
115
– – ﹤0.01% 1165
2023
Q3 		$1.78K Hold
115
– – ﹤0.01% 1158
2023
Q2 		$1.81K Sell
115
-87
-43% -$1.43K ﹤0.01% 1173
2023
Q1 		$3.33K Sell
202
-934
-82% -$14.9K ﹤0.01% 1128
2022
Q4 		$17.7K Buy
+1,136
New +$15.9K ﹤0.01% 932
2022
Q2 		– Sell
-472
Closed -$6.76K – 1293
2022
Q1 		$6.76K Hold
472
– – ﹤0.01% 1078
2021
Q4 		$6.43K Sell
472
-18,893
-98% -$265K ﹤0.01% 938
2021
Q3 		$317K Sell
19,365
-6,765
-26% -$114K 0.01% 463
2021
Q2 		$440K Sell
26,130
-615
-2% -$10.5K 0.02% 425
2021
Q1 		$488K Buy
26,745
+6,157
+30% +$111K 0.02% 395
2020
Q4 		$375K Sell
20,588
-958
-4% -$16.8K 0.02% 413
2020
Q3 		$384K Sell
21,546
-5,551
-20% -$101K 0.02% 387
2020
Q2 		$486K Sell
27,097
-1,716
-6% -$30.8K 0.03% 360
2020
Q1 		$437K Buy
28,813
+10,383
+56% +$188K 0.03% 339
2019
Q4 		$364K Buy
+18,430
New +$353K 0.02% 391

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

TD Private Client Wealth's TAK Position: Q2 2026 in Review

TD Private Client Wealth reduced its Takeda Pharmaceutical (TAK) stake by 7.8% in Q2 2026, selling an estimated $31K and leaving 22,050 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #569.

TD Private Client Wealth first reported a position in TAK in Q4 2019 and has held it in 25 quarters since. The position peaked at $488K in Q1 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • TD Private Client Wealth held 22,050 shares of Takeda Pharmaceutical worth $353K as of Q2 2026.
  • TD Private Client Wealth sold 1,875 Takeda Pharmaceutical shares in Q2 2026, an estimated $31K.
  • Takeda Pharmaceutical made up 0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #569 holding.
  • TD Private Client Wealth first reported a position in Takeda Pharmaceutical in Q4 2019 and has held it in 25 quarters since.
  • TD Private Client Wealth's Takeda Pharmaceutical position peaked at $488K in Q1 2021.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.